Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 21 - Number 4


Review Article (Mini-Review)



Review Article (Mini-Review)


Review Article

PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance

, 21(4): 306 - 325

Sarah F. Giardina*, Elena Valdambrini, J. David Warren and Francis Barany


DOI: 10.2174/1568009621666210203110857



Review Article

The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance

, 21(4): 326 - 352

Shaun Wood, Amber Willbanks and Jason X. Cheng*


DOI: 10.2174/1568009621666210127092828



Review Article   Open Access

Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators

, 21(4): 353 - 359

Stefanie Rauscher, Richard Greil and Roland Geisberger*


DOI: 10.2174/1568009620666210108102723



Research Article

MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types

, 21(4): 360 - 374

Manny D. Bacolod* and Francis Barany


DOI: 10.2174/1568009621666210203111620




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

August-2021-ban

Related Journals

Related eBooks

eBooks Catalog